Copyright
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Transplant. Dec 18, 2025; 15(4): 105732
Published online Dec 18, 2025. doi: 10.5500/wjt.v15.i4.105732
Published online Dec 18, 2025. doi: 10.5500/wjt.v15.i4.105732
Middle- and long-term survival of patients with heart transplant in Mexico from 1988 to 2023: A group experience
Guillermo Careaga-Reyna, Medical Attention Unit, Instituto Mexicano del Seguro Social, Mexico City 06600, Ciudad de México, Mexico
Hugo Jesus Zetina-Tun, Heart Transplant Clinic, Unidad Médica de Alta Especialidad General Hospital “Dr. Gaudencio González Garza” of the Centro Medico Nacional “La Raza”, Instituto Mexicano del Seguro Social, Mexico City 02990, Ciudad de México, Mexico
Co-first authors: Guillermo Careaga-Reyna and Hugo Jesus Zetina-Tun.
Author contributions: Careaga-Reyna G designed and conducted the study and wrote the paper; Zetina-Tun HJ provided the information and contributed to the analysis; Careaga-Reyna G and Zetina-Tun HJ contributed equally as co-first authors.
Institutional review board statement: This study was approved by Bioethics Board (August 18, 2023).
Informed consent statement: The analysis used anonymous clinical data that were obtained after each patient agreed to treatment by written consent.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: No additional data are available.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Guillermo Careaga-Reyna, Chief Physician, Medical Attention Unit, Instituto Mexicano del Seguro Social, Avenue Paseo de la Reforma 476, Mexico City 06600, Ciudad de México, Mexico. gcareaga3@gmail.com
Received: February 6, 2025
Revised: February 27, 2025
Accepted: April 15, 2025
Published online: December 18, 2025
Processing time: 286 Days and 13.7 Hours
Revised: February 27, 2025
Accepted: April 15, 2025
Published online: December 18, 2025
Processing time: 286 Days and 13.7 Hours
Core Tip
Core Tip: In Mexico, ensuring surgical success and immediate survival in heart transplantation recipients constitute a significant challenge. The dilemma arises regarding the medium- and long-term survival of patients receiving heart transplant. The results of this review revealed 1- and 5-year survival rates of 90% and 71%, respectively. Notably, globally, current selection criteria for heart transplant candidates now include patients who were previously deemed ineligible. Adapting short- and long-term treatment and management protocols will be necessary.
